ArticleWiener klinische Wochenschrift2018

Abiraterone acetate, enzalutamide and their sequence for castration-resistant prostate cancer : Adherence, survival and hospitalization analysis of a medical claims database.

Badereddin Mohamad Al-Ali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.